Predictive value of homocysteine for depression after acute coronary syndrome

Hee Ju Kang1, Robert Stewart2, Kyung Yeol Bae1

  • 1Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea.

Oncotarget
|September 15, 2016
PubMed

Insights

High homocysteine levels are linked to depression in acute coronary syndrome (ACS) patients, especially those with the MTHFR TT genotype. This suggests targeted interventions may reduce depression risk post-ACS.

Area of Science:

  • Cardiovascular Medicine
  • Psychiatry
  • Genetics

Background:

  • Depression is a common complication following acute coronary syndrome (ACS).
  • Plasma homocysteine and methylenetetrahydrofolate reductase (MTHFR) gene variants are potential risk factors for depression.
  • Understanding these factors' roles is crucial for managing depression in ACS patients.

Purpose of the Study:

  • To investigate the association between plasma homocysteine, MTHFR genotype, and the risk and persistence of depressive disorder in patients with recent ACS.
  • To examine the influence of these factors on antidepressant treatment response.

Main Methods:

  • A cohort of 969 patients with recent ACS was recruited, with 711 followed up after 1 year.
  • A subset of 378 patients with baseline depressive disorder participated in a 24-week randomized controlled trial of escitalopram versus placebo.
  • Plasma homocysteine levels and MTHFR gene polymorphisms (including TT genotype) were assessed.

Main Results:

  • Higher plasma homocysteine was independently associated with prevalent depressive disorder at baseline, regardless of MTHFR genotype.
  • Elevated homocysteine was linked to incident and persistent depressive disorder at follow-up, but only in patients with the MTHFR TT genotype.
  • MTHFR genotype alone was not associated with depressive disorder after ACS.
  • No significant associations were found between homocysteine, MTHFR genotype, and antidepressant treatment response over 24 weeks.

Conclusions:

  • Plasma homocysteine may serve as a valuable biomarker for depressive disorder, particularly during the acute phase of ACS.
  • Interventions targeting individuals with high homocysteine levels and the MTHFR TT genotype could potentially mitigate the risk of developing depression post-ACS.
  • Further research is warranted to explore the therapeutic implications of these findings.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
684
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
369
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
827
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
376
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K